Overview


According to FutureWise analysis the market for at home diagnostics in 2023 is US$ 6.1 billion, and is expected to reach US$ 9.5 billion by 2031 at a CAGR of 6%.

At-home diagnostics refers to the use of diagnostic tests or tools that can be self-administered or used in a home setting, without the need for a healthcare professional or specialized medical equipment. At-home diagnostics can include a variety of tests such as blood glucose monitoring, pregnancy tests, and home HIV tests. At-home diagnostics have become increasingly popular and accessible due to increased consumer demand for convenient, affordable, and accurate health solutions. Many at-home diagnostic tests are now available over-the-counter, and some can be ordered online and delivered directly to a person's home. At-home diagnostics can range from simple self-examinations, such as measuring body temperature or checking for lumps or bumps, to more complex tests, such as blood glucose monitoring or genetic testing. Some tests can be performed with the help of over-the-counter kits, while others require specialized equipment or training.

Advances in technology have made at-home diagnostics more accessible and convenient. For example, individuals can use home testing kits to measure blood pressure, cholesterol levels, or even check for infections like STIs or UTIs. Some devices, such as smartwatches and fitness trackers, can also monitor heart rate and activity levels, giving users an indication of their overall health and fitness. At-home diagnostics can be more cost-effective than traditional medical tests. Many tests can be performed at a fraction of the cost of in-person visits, and some tests may be covered by insurance.

FutureWise Market Research has published a report that provides an insightful analysis of Global at Home Diagnostics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Global at Home Diagnostics Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Chembio Diagnostics, Inc.
  • Quidel Corp
  • Nectar Lifesciences Ltd (Rapikit) 
  • Bionime Corp
  • Becton, Dickinson & Co.
  • PRIMA Lab
  • Atlas Medical UK  
  • OraSure Technologies
  • B. Braun Melsungen AG
  • Lifescan Inc
  • Troge Medical Gmbh
  • Nova Biomedical
  • Siemens Healthcare
  • Cardinal Health, Inc
  • EmsiG GmbH  Co
  •  Acon Laboratories Inc.
  • Trividia Health, Inc.
  • TaiDoc Technology Corporation

Recent developments by key players in Global At Home Diagnostics Market:

In April 2021, to enhance access to HIV self-testing in Low and Middle-Income Countries, Viatris and Atomo Diagnostics had committed to working with Unitaid, with an aim to make HIV testing available in 135 countries, the Unitaid expansion programme had financed the distribution of up to 1 million HIV self-test kits.

The global at-home diagnostic market is a rapidly growing industry driven by various factors, such as the increasing incidence of chronic illnesses, rising awareness about preventive healthcare, technological advancements, and the growing demand for personalized medicine. The COVID-19 pandemic has influenced the growth of this market as people have become more cautious about visiting hospitals and clinics, leading to a higher demand for at-home diagnostic tests. One of the major factors driving the expansion of the at-home diagnostic market is the increasing prevalence of chronic disorders including diabetes, cancer, cardiovascular diseases, and respiratory diseases. The availability of at-home diagnostic tests allows patients to monitor their health regularly, which can help in early detection of these diseases and prevent further complications. Moreover, there is a growing trend of people taking control of their health and being proactive about preventative care. At-home diagnostic tests provide a convenient and accessible way to monitor one's health without regular visits to healthcare facilities.

Furthermore, the demand for personalized medicine has also driven the growth of the at-home diagnostic market. At-home diagnostic tests can provide a more customized approach to healthcare by allowing patients to monitor their health more closely and tailor their treatment plans accordingly. However, the global at-home diagnostic market faces restraints that could hinder its growth. These restraints include a lack of standardization, regulatory challenges, limited test accuracy, limited availability of advanced tests, and limited reimbursement. Despite these challenges, the market is expected to continue to grow in the forecast period.

By Test Type

  • Glucose Tests
  • Pregnancy Test
  • Infections Disease Test
    • HIV Test
    • Urinary and Genital Infection
    • Others
  • Drug Abuse Test
  • Ovulation Predictor Test
    • Ovulation-LH Test
    • Menopause-FSH Test
    • Sperm Test   
  • Cholesterol and Triglycerides Tests
  • Other Test Type

By Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  • Dip Card
  • Others

By Sample Type

  • Blood
  • Urine
  • Saliva
  • Serum
  • Others

By Distribution Channel

  • Retail Pharmacies
  • Drug Stores
  • Supermarket/Hypermarket
  • Online Pharmacies

By Region

  • North America 
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America dominated the worldwide global at home diagnostics market and is expected to maintain its dominance in the years to come. In 2020, the U.S. held a market share of almost 90% in North America. This is a result of rising healthcare spending per person. The amount spent on healthcare per person in the US in 2020 was reported to be approximately $10,264. In addition, rising chronic illness occurrences, higher consumer awareness of home diagnostics, expanding geriatric populations, and increased consumer disposable income all played a significant role in the market's expansion in North America. Additionally, on a global scale, based on type; cassettes hold highest market share of 38.9%, followed by strips holding a market share of 24.7% in 2022.
  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth
  • To provide with an exhaustive analysis on the of Global At Home Diagnostics Market By Test Type, By Type, By Sample Type, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   At Home Diagnostics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of At Home Diagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   At Home Diagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   At Home Diagnostics Market, By Test Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Glucose Tests
        2. Pregnancy Test
        3. Infections Disease Test
         3.1. HIV Test
         3.2. Urinary and Genital Infection
         3.3. Others
        4. Drug Abuse Test
        5. Ovulation Predictor Test
         5.1 . Ovulation-LH Test
         5.2 . Menopause-FSH Test
         5.3 . Sperm Test
        6. Cholesterol and Triglycerides Tests
        7. Other Test Type

  • 8.   At Home Diagnostics Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Cassette
        2. Strip
        3. Midstream
        4. Test Panel
        5. Dip Card
        6. Others

  • 9.  At Home Diagnostics Market, By Sample Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Urine
        2. Blood
        3. Saliva
        4. Serum
        5. Others

  • 10.  At Home Diagnostics Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Retail Pharmacies
        2. Drug Store
        3. Supermarket/Hypermarket
        4. Online Pharmacies

  • 11.   North America At Home Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America At Home Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe At Home Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific At Home Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. F. Hoffmann-La Roche Ltd
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Chembio Diagnostics, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Quidel Corp
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Nectar Lifesciences Ltd (Rapikit)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bionime Corp
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Becton, DickinsonCo.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. PRIMA Lab
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Atlas Medical UK
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. OraSure Technologies
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. B. Braun Melsungen AG
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Lifescan Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Troge Medical Gmbh
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Nova Biomedical
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Siemens Healthcare
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Cardinal Health, Inc
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. EmsiG GmbH Co
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Acon Laboratories Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Trividia Health, Inc.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. TaiDoc Technology Corporation
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

FAQ


Our market forecast takes into account a variety of factors to provide the most comprehensive analysis. These include:

  • Current market trends and future predictions.
  • Technological advancements impacting at-home testing kits.
  • Regulatory policies and their influence on market dynamics.
  • The impact of global health situations on the demand for at-home diagnostics.
  • Consumer behavior and preferences towards home-based healthcare.
  • Competitive landscape and key market players' strategies.
  • Economic indicators and their effect on market growth.

Yes, our market forecast incorporates emerging trends in the health-tech industry that are likely to influence the at-home diagnostics market. This ensures that readers stay informed about the latest innovations and their potential impacts on the market.

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11